These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10888360)

  • 1. Effect of the sialyl Lewis X (SLe(x)) moiety on splenic accumulation of SLe(x)-carboxymethylpullulan conjugate.
    Horie K; Sakagami M; Kuramochi K; Ito T; Hamana H
    Microbiol Immunol; 2000; 44(5):401-4. PubMed ID: 10888360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced accumulation of sialyl Lewis X-carboxymethylpullulan conjugate in acute inflammatory lesion.
    Horie K; Sakagami M; Kuramochi K; Hanasaki K; Hamana H; Ito T
    Pharm Res; 1999 Feb; 16(2):314-20. PubMed ID: 10100320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialyl Lewis X-carboxymethylpullulan conjugate: a novel homing device to spleen and lymph nodes.
    Horie K; Sakagami M; Masuda K; Notoya M; Hamana H; Yoshikawa T; Hirano K
    Biol Pharm Bull; 2004 Aug; 27(8):1275-80. PubMed ID: 15305036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of carboxymethylpullulan as a novel carrier for targeting immune tissues.
    Masuda K; Sakagami M; Horie K; Nogusa H; Hamana H; Hirano K
    Pharm Res; 2001 Feb; 18(2):217-23. PubMed ID: 11405294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents.
    Nogusa H; Yamamoto K; Yano T; Kajiki M; Hamana H; Okuno S
    Biol Pharm Bull; 2000 May; 23(5):621-6. PubMed ID: 10823676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of sialyl Lewis X-polysaccharide conjugates.
    Sakagami M; Horie K; Nakamoto K; Kawaguchi T; Hamana H
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1256-63. PubMed ID: 10993222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
    Hashida N; Ohguro N; Yamazaki N; Arakawa Y; Oiki E; Mashimo H; Kurokawa N; Tano Y
    Exp Eye Res; 2008 Jan; 86(1):138-49. PubMed ID: 18036523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates.
    Nogusa H; Hamana H; Uchida N; Maekawa R; Yoshioka T
    Jpn J Cancer Res; 2000 Dec; 91(12):1333-8. PubMed ID: 11123434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure--activity relationships of sialyl Lewis x-containing oligosaccharides. 1. Effect of modifications of the fucose moiety.
    Ramphal JY; Zheng ZL; Perez C; Walker LE; DeFrees SA; Gaeta FC
    J Med Chem; 1994 Oct; 37(21):3459-63. PubMed ID: 7523674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl Lewis X-polysaccharide conjugates: targeting inflammatory lesions.
    Sakagami M; Horie K; Nakamoto K; Kawaguchi T; Hamana H
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2783-6. PubMed ID: 9873622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma.
    Renkonen J; Paavonen T; Renkonen R
    Int J Cancer; 1997 Jun; 74(3):296-300. PubMed ID: 9221808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoenzymatic synthesis and fluorescent visualization of cell-surface selectin-bound sialyl Lewis x derivatives.
    Wittmann V; Datta AK; Koeller KM; Wong CH
    Chemistry; 2000 Jan; 6(1):162-71. PubMed ID: 10747401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
    Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
    Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of carboxymethylpullulan-peptide-doxorubicin conjugates and their properties.
    Nogusa H; Yano T; Okuno S; Hamana H; Inoue K
    Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1931-6. PubMed ID: 8575033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects and toxicities of carboxymethylpullulan-peptide-doxorubicin conjugates.
    Nogusa H; Yano T; Kajiki M; Gonsho A; Hamana H; Okuno S
    Biol Pharm Bull; 1997 Oct; 20(10):1061-5. PubMed ID: 9353565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human and mouse E-selectin binding to Sialyl-Lewis(x).
    Rocheleau AD; Cao TM; Takitani T; King MR
    BMC Struct Biol; 2016 Jul; 16(1):10. PubMed ID: 27368167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of sialyl Lewis(X) glycosphingolipid microdomains in model membranes as selectin recognition motifs using a fluorescence label.
    Gege C; Schumacher G; Rothe U; Schmidt RR; Bendas G
    Carbohydr Res; 2008 Sep; 343(14):2361-8. PubMed ID: 18656853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on selectin blockers. 4. Structure-function relationships of sulfated sialyl Lewis X hexasaccharide ceramides toward E-, P-, and L-selectin binding.
    Yoshino K; Ohmoto H; Kondo N; Tsujishita H; Hiramatsu Y; Inoue Y; Kondo H
    J Med Chem; 1997 Feb; 40(4):455-62. PubMed ID: 9046335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors.
    Kaila N; Thomas BE
    Med Res Rev; 2002 Nov; 22(6):566-601. PubMed ID: 12369089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
    Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
    Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.